
Haisco Pharmaceutical Group Co Ltd
SZSE:002653

Intrinsic Value
The intrinsic value of one
Haisco Pharmaceutical Group Co Ltd
stock under the Base Case scenario is
20.68
CNY.
Compared to the current market price of 44.4 CNY,
Haisco Pharmaceutical Group Co Ltd
is
Overvalued by 53%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Haisco Pharmaceutical Group Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Haisco Pharmaceutical Group Co Ltd
Balance Sheet Decomposition
Haisco Pharmaceutical Group Co Ltd
Current Assets | 2.9B |
Cash & Short-Term Investments | 1.3B |
Receivables | 1.2B |
Other Current Assets | 385.8m |
Non-Current Assets | 4B |
Long-Term Investments | 399m |
PP&E | 987.8m |
Intangibles | 2.3B |
Other Non-Current Assets | 350.7m |
Free Cash Flow Analysis
Haisco Pharmaceutical Group Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Haisco Pharmaceutical Group Co Ltd
Revenue
|
3.7B
CNY
|
Cost of Revenue
|
-1.1B
CNY
|
Gross Profit
|
2.6B
CNY
|
Operating Expenses
|
-2.1B
CNY
|
Operating Income
|
506.5m
CNY
|
Other Expenses
|
-30.3m
CNY
|
Net Income
|
476.2m
CNY
|
Profitability Score
Profitability Due Diligence
Haisco Pharmaceutical Group Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Score
Haisco Pharmaceutical Group Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Haisco Pharmaceutical Group Co Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Score
Haisco Pharmaceutical Group Co Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Haisco Pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for
Haisco Pharmaceutical Group Co Ltd
is 38.53 CNY
with a low forecast of 33.5 CNY and a high forecast of 44.5 CNY.
Dividends
Current shareholder yield for Haisco Pharmaceutical Group Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Haisco Pharmaceutical Group Co Ltd
stock under the Base Case scenario is
20.68
CNY.
Compared to the current market price of 44.4 CNY,
Haisco Pharmaceutical Group Co Ltd
is
Overvalued by 53%.